The largest database of trusted experimental protocols

Phospho pi3k

Manufactured by Abcam
Sourced in United States

Phospho-PI3K is a lab equipment product that detects and quantifies the phosphorylation of the phosphoinositide 3-kinase (PI3K) enzyme. PI3K plays a crucial role in various cellular processes, including cell growth, proliferation, and survival. This product allows researchers to measure the activation state of PI3K, which is important for understanding signaling pathways and cellular responses in a variety of experimental systems.

Automatically generated - may contain errors

7 protocols using phospho pi3k

1

Quantitative Western Blotting of Akt Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as previously described [25 (link)] using antibodies against RhoB (1:500; Proteintech, USA), phospho-Akt 308, phospho-Akt 473 and Akt (1:1,000; Cell Signaling Technology, USA), phospho-PI3K (1:1,000; Abcam, USA), PI3K (1:1,000; Cell Signaling Technology, USA), P-glycoprotein (P-gp, also known as ABCB1) (1:500; Proteintech, USA), breast cancer resistance protein (BCRP, also known as ABCG2) (1:500; Proteintech, USA), multidrug resistance-associated protein 1 (MRP1, also known as ABCC1) (1:500; Abcam, USA) and β-actin (1:5,000; Cell Signaling Technology, USA). The secondary antibody used is horseradish peroxidase-conjugated antibody (anti-rabbit; 1:5,000; Cell Signaling Technology). Protein levels were normalized to the endogenous control β-actin.
+ Open protocol
+ Expand
2

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed by RIPA. After being shocked and ice-bath for 30 min, cells were centrifuged for 20 min at 22,000 rpm at 4°C. The supernatants were collected. Cell membrane protein and cytoplasmic protein were separated using Mem-PERTM Plus Membrane Protein Extraction Kit (Thermo). The concentration of protein was accessed using BCA. 20–40 μg protein was separated by 8–12.5% SDS-PAGE, then transferred to polyvinylidene fluoride membrane (Immobilon-P) using Trans-Blot Turbo Transfer System (Bio-Rad). DMT1, IRP1, IRP2, TfR1, TfR2, ferritin, T-PI3K, phospho-PI3K antibodies were obtained from Abcam. T-STAT3 (0.1 mg/ml), phospho-STAT3 tyr705 (1 mg/ml) were acquired from R&D. T-ERK, phospho-ERK, pan-AKT, phospho-AKT (1:1000) were obtained from Cell signaling technology. GAPDH and β-actin antibodies were purchased from Biotime. After being cultured with primary antibodies overnight at 4 °C, proteins were cultured with the HRP-labeled secondary antibody (KPL). Proteins were visualized using enhanced chemiluminescence (Pierce). All experiments were performed in triplicate.
+ Open protocol
+ Expand
3

Western Blot Analysis of Apoptosis and Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 40 mg of protein lysate was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to a polyvinylidene fluoride (PVDF) membrane (Bio-Rad). The primary antibodies were against cleaved caspase-3 (12742; Cell Signaling Technology, Danvers, MA, USA), cleaved poly(ADP-ribose) polymerase (PARP) (9541; Cell Signaling Technology), BAX (5023; Cell Signaling Technology), ZNF545 (sc-102235; Santa Cruz Biotechnology, Santa Cruz, CA, USA), PI3K (ab125571; Abcam, Cambridge, UK), phospho-PI3K (Abcam), Akt (4691; Cell Signaling Technology), phospho-Akt (ser473) (4060; Cell Signaling Technology), phospho-GSK3β (ser9) (9323; Cell Signaling Technology), β-catenin (2677; Cell Signaling), active β-catenin (4270; Cell Signaling), c-Myc (1472-1; Epitomic), cyclin D1 (2261; Epitomics), β-actin (LK-ab008-100; Liankebio, China), and Flag (F3165; Sigma-Aldrich).
+ Open protocol
+ Expand
4

Western Blotting Analysis of PI3K/Akt Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described in our previous study [11 (link),13 (link)]. Meg-01 cells were lysed with protein lysis buffer (P0013, Beyotime Biotechnology, Haimen, China) containing a protease inhibitor cocktail (539131, Millipore, Billerica, MA, USA) and phosphatase inhibitor cocktail (K1012, APExBIO, Houston, TX, USA). The samples (20 μg) were then separated by 8% SDS-PAGE gel and transferred onto PVDF membranes. The PDVF membranes were incubated with primary antibodies at 4 °C for 12 h. After incubating with the appropriate HRP-conjugated secondary antibodies (7076, 7074, Cell Signaling Technology, Danvers, MA, USA), blots were detected with chemiluminescent HRP substrate (P90719, Millipore, Billerica, MA, USA) using the ChemiDoc XRS+ system (BIO-RAD, Hercules, CA, USA). Primary antibodies against the following antigens were listed: PI3K (4257, Cell Signaling Technology, Danvers, MA, USA), Phospho-PI3K (ab226842, Abcam, Cambridge, UK), Akt (4691, Cell Signaling Technology, Danvers, MA, USA), Phospho-Akt (4056, Cell Signaling Technology, Danvers, MA, USA), and β-actin (66009-1, Proteintech, Rosemont, IL, USA).
+ Open protocol
+ Expand
5

Protein Expression Analysis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from tissue samples or cells. Total protein concentration was determined using a bicinchoninic acid (BCA) kit for protein determination (Takara). The samples were resolved in 10% SDS-PAGE gels and transferred to polyvinylidene fluoride (PVDF) membranes. Immunoblots were probed with primary antibodies overnight at 4°C. The following antibodies used were from Abcam: H3R (1:1000), E-cadherin (1:10000), N-cadherin (1:5000), ZO-1 (1:50), vimentin (1:1000), phospho-PI3K (Tyr607)(1:500). The following antibodies were from Cell Signaling: phospho-Akt (Ser473) (1:1000), Akt (1:1000), phospho-ERK1/2 (Thr202/Tyr204)(1:1000), ERK1/2 (1:1000), phospho-MEK1/2 (Ser217/Ser221)(1:1000), MEK1/2 (1:1000), PI3K (1:1000) and β-actin (1:1000). All primary antibodies were used according to the instructions provided by the supplier. After that, the membrane was incubated with the corresponding HRP-linked anti-rabbit IgG antibody (1:2000, Cell signaling) at room temperature for 1 h. The blots were visualized using the ECL-Plus reagent (Millipore).
+ Open protocol
+ Expand
6

Synthesis and Identification of LXQ46

Check if the same lab product or an alternative is used in the 5 most similar protocols
LXQ46 (3,4-dibromo-5-(5-(4-(4-ethoxyphenoxy)phenyl)oxazol-2-yl)benzene-1,2-diol) was synthesized and identified by our lab (purity 98%). Primary antibodies used in this study: PTP1B (#133259) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). PARP (#9532), Bcl-xL (#2764), Phospho-AMPK (Thr172, #2535), AMPK (#2793S), Phospho-Akt (Ser473, #4060), Akt (#4685), Phospho-ERK (Thr202/Tyr204, #4370S), ERK (#4696S), Phospho-PRAS40 (#2640) and Ki67 (#9027) were purchased from Cell Signaling Technology (Danvers, MA, USA). Bax (#32503), Bcl-2 (#32124), CDK2 (#32147), CDK4 (#108357), CDK6 (#124821), Cyclin D1(#134175), Phospho-Src (Tyr529, #32078), Src (#47405), Phospho-PI3K (#182651), PI3K (#86714), PRAS40 (#151719) were purchased from Abcam (Cambridge, MA, USA). Phospho-p70 S6 Kinase (Thr389/412, #3228) and p70 S6 Kinase (#6226), Phospho-PKM2 (Tyr105 #7771), PKM2 (#5234) were purchased from Affinity Biosciences (Cincinnati, OH, USA). β-actin antibody and all secondary antibodies were obtained from Proteintech Group (Wuhan, China).
+ Open protocol
+ Expand
7

Signaling Pathway Profiling in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
TPC‐1 and CAL‐62 cells were treated with protein lysates containing protease inhibitors. Each group maintained the same concentration of total protein, and proteins were separated using sodium dodecyl sulfate‐polyacrylamide gel electrophoresis and then transferred onto polyvinylidene difluoride membranes. The protein‐containing membranes were then treated with 5% fat‐free milk and primary antibodies (TBK1, MAZ, phospho‐PI3K [p‐PI3K], PI3K, phospho‐Akt [p‐Akt], Akt, phospho‐mTOR [p‐mTOR], and mTOR; Abcam). The membranes were then treated with a secondary antibody (Abcam) for 1 h. The proteins were imaged by an Enhanced Chemiluminescent Kit (Thermo Fisher Scientific) and analyzed by ImageJ (V1.50b; NIH).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!